Insurance coverage for fertility preservation depends on your clinical diagnosis, state laws, and specific employer benefit package. Most standard commercial health plans exclude elective or age-related egg and sperm freezing. However, a growing number of states require fully insured group plans to cover medically necessary fertility preservation when medical treatments, such as chemotherapy, radiation, or pelvic surgery, threaten future reproductive health. Even with coverage, medication, lab fees, and long-term storage often involve separate rules.
Navigating reproductive health benefits can be stressful, particularly when you are managing a major medical diagnosis or planning your long-term reproductive timeline alongside complex policy documents and shifting health regulations.
Medical Necessity Versus Elective Egg and Sperm Freezing
Insurers divide fertility preservation into two primary categories: medical (often called iatrogenic) preservation and elective or planned preservation. Medical preservation applies when a patient faces a disease, medical condition, or treatment that will directly cause irreversible infertility or severe impairment of reproductive function. Common examples include oncology protocols involving chemotherapy or radiation therapy, severe autoimmune conditions requiring immunosuppressive drug regimens, gender-affirming surgeries, and surgical procedures requiring the removal of the ovaries or testes. In these circumstances, the procedure is treated as a proactive medical intervention intended to preserve an essential bodily function before medical damage occurs.
Elective or planned fertility preservation refers to cryopreserving gametes (eggs or sperm) or embryos to protect against natural age-related reproductive decline or to defer childbearing for personal, educational, or professional reasons. The vast majority of standard private health insurance policies classify elective freezing as a non-covered service, categorizing it as an optional lifestyle procedure rather than a medically necessary treatment. While some progressive employers offer dedicated supplemental fertility benefits that include elective freezing as a recruitment or retention perk, standard commercial policies almost universally exclude preservation in the absence of a qualifying medical diagnosis.
Further reading: Office on Women's Health
State Mandates and Employer Plan Exemptions
State legislation plays a major role in determining whether your insurance policy includes fertility preservation benefits. Multiple US states have passed laws requiring certain health plans to cover medically necessary fertility preservation for patients facing treatments that cause iatrogenic infertility. However, these state laws vary widely in their scope. Some state mandates require coverage for both mature egg and sperm cryopreservation, while others explicitly include embryo creation, diagnostic testing, and a defined duration of cryostorage. The specific qualifying medical conditions also vary, with certain states limiting coverage strictly to cancer diagnoses and others extending coverage to any treatment that impairs reproductive capacity.
Even if you reside in a state with a comprehensive fertility preservation mandate, your policy might still be exempt from state rules. State insurance mandates generally apply only to state-regulated, fully insured health plans. If you receive health coverage through a large employer that sponsors a self-funded (self-insured) plan, that plan is governed by federal law under the Employee Retirement Income Security Act (ERISA) and is not legally bound by state insurance mandates. Federal employee health plans, military health benefits, and Medicare also follow their own distinct guidelines rather than state-level insurance legislation. To know where you stand, you must confirm whether your employer's plan is fully insured or self-funded.
How Insurers Break Down the Fertility Preservation Pipeline
Fertility preservation is not billed as a single, all-inclusive medical procedure. Instead, the process involves multiple phases, clinical specialties, and facility bills, each of which insurers evaluate separately under different benefit categories. The first phase includes diagnostic blood tests, infectious disease screening, genetic carrier testing, and pelvic ultrasounds to evaluate baseline ovarian or testicular function. These diagnostic evaluations are frequently processed under standard outpatient medical benefits, though laboratory network restrictions still apply.
The subsequent phases introduce distinct clinical and financial components that require specific benefit verification. For female patients, ovarian stimulation requires high-dose injectable gonadotropins, which are processed through pharmacy benefits rather than general medical benefits and often require separate specialty pharmacy authorization. The surgical retrieval involves surgeon fees, facility charges, and anesthesiology services. Following retrieval, the embryology laboratory assesses, prepares, and vitrifies the gametes or embryos. Finally, long-term cryostorage requires annual maintenance fees. A health plan might agree to cover the retrieval procedure while explicitly denying coverage for the fertility medications, specialized laboratory techniques, or ongoing storage fees.
Further reading: Office on Women's Health
Further reading: CDC: Contraception and birth control methods
Navigating Prior Authorization and Medical Necessity Documentation
Securing insurance approval for fertility preservation requires thorough documentation and clear coordination between your treating medical specialist (such as an oncologist, rheumatologist, or surgeon) and a reproductive endocrinology and infertility specialist. The process begins with a formal prior authorization request submitted to your health plan before starting any stimulation protocols or clinical procedures. If you are facing an urgent treatment schedule, such as starting cancer therapy within days or weeks, your medical team must request an expedited or urgent review to avoid treatment delays.
A successful prior authorization submission relies on precise clinical coding and documentation. The treating specialist must submit a detailed letter of medical necessity establishing the diagnosis, the recommended gonadotoxic treatment plan, and the expected risk to fertility. The fertility clinic provides the corresponding diagnostic codes (ICD-10) and procedure codes (CPT) for each intended service, including monitoring ultrasounds, blood draws, surgical retrieval, and cryopreservation. If any required code is omitted or if the clinical notes fail to connect the preservation procedure directly to the underlying medical risk, the initial authorization request is likely to be rejected.
Managing Claim Denials and Filing Appeals
Receiving an insurance denial for fertility preservation can feel discouraging, but an initial denial is often an administrative barrier rather than a final verdict. The first step in addressing a denial is requesting the formal Explanation of Benefits and a written denial letter from the insurer. This document must state the exact reason for the denial, such as lack of medical necessity, missing clinical documentation, an out-of-network provider, or an explicit plan exclusion. Identifying the specific reason allows you and your clinical care team to build an appeal that directly addresses the insurer's cited rationale.
The appeals process typically includes internal and external review levels. During an internal appeal, your reproductive specialist or treating physician can request a peer-to-peer discussion with the insurance medical director to explain the clinical urgency and the medical rationale for the procedure. If the internal appeal is upheld and your policy is subject to state insurance oversight, you may have the right to request an independent external review conducted by an outside panel of medical professionals. Throughout this process, maintain a chronological log of all phone calls, representative names, case reference numbers, and written correspondence to support your case.
Alternative Financing and Financial Assistance Options
When health insurance denies coverage or provides only partial reimbursement, patients must explore alternative methods to manage the out-of-pocket costs of fertility preservation. Several non-profit organizations and disease-specific advocacy foundations offer dedicated financial grants to assist individuals facing medical treatments that threaten their fertility. These grants often provide direct funding toward clinical retrieval fees, specialized laboratory processing, or initial storage charges.
Pharmaceutical companies that manufacture fertility medications also offer compassionate care and patient assistance programs. These programs provide discounted or free stimulation medications to qualifying patients diagnosed with cancer or specific medical conditions requiring rapid preservation. Additionally, fertility clinics frequently offer self-pay package rates that combine monitoring, retrieval, and laboratory vitrification into a single discounted fee, alongside dedicated medical financing loans with structured payment terms. Exploring these options early helps minimize financial barriers when timing is critical.
Frequently asked questions
Does insurance usually pay for the annual storage fees of frozen eggs or sperm?
Most standard insurance plans do not cover ongoing annual storage fees, even if they covered the initial retrieval and freezing procedure. Some plans that include comprehensive fertility benefits or state-mandated coverage may pay for a limited initial period, such as one to three years, after which the patient is responsible for recurring annual out-of-pocket storage charges.
What questions should I ask my insurance company to check my fertility preservation benefits?
Contact your insurer's member services department and ask if your plan covers CPT codes for egg, sperm, or embryo retrieval and cryopreservation under your specific diagnosis. Clarify whether your plan is fully insured or self-funded, whether pre-authorization is required, which specialty pharmacy supplies your medications, and whether storage fees are included.
Will insurance cover fertility preservation before gender affirmation surgery or hormone therapy?
Coverage depends on your specific policy language, state regulations, and whether the insurer recognizes gender-affirming medical treatments as causing iatrogenic infertility. While an increasing number of plans and state mandates recognize these medical needs, some policies still have restrictive definitions that require clinical appeals.
What happens to frozen samples if I change health insurance plans later?
Your frozen gametes or embryos remain your legal property and stay safely in storage at the fertility clinic or cryobanking facility regardless of changes to your health insurance. However, if your prior insurer was covering your annual storage fees, you must check whether your new health plan offers storage reimbursement or if you will need to pay those fees out of pocket.
Your next step
Call your health insurance provider's member services line today to request a complete Summary Plan Description and ask specifically for their written medical policy on fertility preservation and cryopreservation codes.